Alissa Hsu Lynch

LUNG

Alissa Hsu Lynch serves as Director at Pulmonx Corporation (LUNG). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$9.4K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$9.4K

Companies Traded

LUNG

Active Period

Dec 2022

1 total trades

Most Recent

Buy LUNG

Dec 1, 2022 · $9.4K

Alissa Hsu Lynch's Insider Trading at Pulmonx Corporation (LUNG)

Buys

1 · $9.4K

Sells

0 · $0.00

Total Shares Bought

1,700

Total Shares Sold

LUNG Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 1, 2022↗	Buy	1,700	$5.51	$9.4K	11,910

Related Insiders

Srikanth Radhakrishnan

officer: Chief Science &Techn. Officer

LUNGSell · Mar 2, 2026

Geoffrey Beran Rose

officer: CHIEF COMMERCIAL OFFICER

LUNGSell · Mar 2, 2026

Glendon E. French III

director, officer: President and CEO

LUNGSell · Mar 2, 2026

David Aaron Lehman

officer: GENERAL COUNSEL

LUNGSell · Mar 2, 2026

Daniel P Florin

Director

LUNGSell · Dec 8, 2025

Glendon E. French III

President and CEO

LUNGSell · Dec 1, 2025

Geoffrey Beran Rose

CHIEF COMMERCIAL OFFICER

LUNGSell · Dec 1, 2025

David Aaron Lehman

GENERAL COUNSEL

LUNGSell · Dec 1, 2025

Explore More Insider Trading Data

LUNG Insider Trading Activity

View all insider trades at Pulmonx Corporation

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity